Woodline Partners’s Apollo Endosurgery, Inc. APEN Stock Holding History

Woodline Partners’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,809,001	Closed	-$17.9M	–	834
2023 Q1	$17.9M	Buy	1,809,001 +1,046,201	+137%	+$10.4M	0.24%	119
2022 Q4	$7.61M	Buy	+762,800	New	+$5.69M	0.1%	249

Woodline Partners's APEN Position: Q2 2023 in Review

Woodline Partners sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 1,809,001 shares — an estimated $17.9M sold.

Woodline Partners first reported a position in APEN in Q4 2022 and held it in 2 quarters. The position peaked at $17.9M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Woodline Partners reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Woodline Partners sold 1,809,001 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $17.9M.
Woodline Partners first reported a position in Apollo Endosurgery, Inc. in Q4 2022 and held it in 2 quarters.
Woodline Partners's Apollo Endosurgery, Inc. position peaked at $17.9M in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.